Role of selegiline in combination therapy of Parkinson's disease

Neurology. 1996 Dec;47(6 Suppl 3):S200-9. doi: 10.1212/wnl.47.6_suppl_3.200s.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Drug Therapy, Combination
  • Humans
  • Levodopa / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Selegiline / therapeutic use*

Substances

  • Antiparkinson Agents
  • Selegiline
  • Levodopa